Not applicableStudy completedNCT02065817What this trial is testingDose of Labeled Cholesterol for Kinetics: A Pilot StudyWho this might be right forLipid Metabolism Mayo Clinic 7
Not applicableLooking for participantsNCT00353782What this trial is testingCauses and Natural History of DyslipidemiasWho this might be right forHypercholesterolemiaAtherosclerosis National Heart, Lung, and Blood Institute (NHLBI) 2,000
Post-approval studies (Phase 4)Study completedNCT00282659What this trial is testingThe Use of Magnesium to Improve Blood Pressure, Cholesterol, and Glucose ControlWho this might be right forCoronary Artery DiseaseHypertensionDyslipidemia+1 more Hartford Hospital 240
Not applicableStudy completedNCT06693947What this trial is testingImpact of Alpine Dairy Products on Blood Lipid LevelsWho this might be right forElevated Cholesterol University of Fribourg 29
Early research (Phase 1)Study completedNCT01894217What this trial is testingStatin Therapy to Improve Medication AdherenceWho this might be right forHypercholesterolemiaHMG COA Reductase Inhibitor Adverse Reaction Duke University 63
Not applicableStudy completedNCT01483950What this trial is testingEvaluation of Patients Treated With HMG-CoA Reductase Inhibitors to Reach Cholesterol Target ValuesWho this might be right forHypercholesterolaemia AstraZeneca 800
Post-approval studies (Phase 4)UnknownNCT03277079What this trial is testingLow Dose Statins, Ezetimibe and NutraceuticalsWho this might be right forCoronary Artery Disease University of Roma La Sapienza 100
Post-approval studies (Phase 4)Study completedNCT00644670What this trial is testingThe Efficacy Of Atorvastatin For Lowering Cholesterol In High-Risk Patients With High CholesterolWho this might be right forDyslipidemias Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 232
Not applicableActive Not RecruitingNCT04156997What this trial is testingExtreme Lipids RepositoryWho this might be right forLipoprotein Disorder University of Texas Southwestern Medical Center 250
Large-scale testing (Phase 3)Study completedNCT01370603What this trial is testingEvaluate the Effectiveness of Ezetimibe/Atorvastatin 10 mg/40 mg Combination Tablet Compared to Marketed Ezetimibe 10 mg and Atorvastatin 40 mg Tablets in Participants With High Cholesterol (MK-0653C-190 AM1)Who this might be right forHypercholesterolemia Organon and Co 328
Early research (Phase 1)Study completedNCT02163161What this trial is testingAStudy to Evaluate the Bioavailability of PF 04965842 in Healthy SubjectsWho this might be right forHealthy Pfizer 12
Not applicableStudy completedNCT00826631What this trial is testingHow Does 4 Weeks of Increased Fast Food Intake Affect Metabolism?Who this might be right forHyper-AlimentationHealthy University Hospital, Linkoeping 36
Early research (Phase 1)Study completedNCT01380496What this trial is testingBioequivalence Study of Doxycycline Monohydrate Tablets Under Fed ConditionsWho this might be right forTo Determine Bioequivalence Under Fed Conditions Par Pharmaceutical, Inc. 24
Not applicableStudy completedNCT03903029What this trial is testingEfficacy of Low-dose (10 mg) Rosuvastatin in Korean 4 Statin Benefit Groups Per 2013 ACC/AHA GuidelineWho this might be right forDyslipidemias Seoul National University Hospital 242
Post-approval studies (Phase 4)Study completedNCT00307307What this trial is testingCarotid Atherosclerosis Regression at Magnetic Resonance Assessment.Who this might be right forEstablished Carotid Atherosclerosis University of Pennsylvania 69
Not applicableLooking for participantsNCT06231966What this trial is testingRandomized Comparison of Efficacy and Safety of High-intensity Rosuvastatin/Ezetimibe Combination Versus Treat-to-target Rosuvastatin Monotherapy for Patients With Peripheral Artery or Polyvascular Disease (CARE-PVD Trial)Who this might be right forPeripheral Artery DiseasePolyvascular Disease Yonsei University 2,462
Large-scale testing (Phase 3)Study completedNCT00654602What this trial is testing48-wk Open Label Phase IIIb to Evaluate Efficacy and SafetyWho this might be right forDyslipidaemia AstraZeneca 1,500
Not applicableStudy completedNCT02373319What this trial is testingSelf-screening of Cardiovascular RiskWho this might be right forRisk Factor, Cardiovascular Parc de Salut Mar 960
Not applicableStudy completedNCT02033694What this trial is testingThe Lipid-Rich Plaque StudyWho this might be right forCoronary Artery DiseaseAtherosclerosis Infraredx 1,563
Not applicableStudy completedNCT00999453What this trial is testingThe Effects of Lowering Low-density Lipoprotein Cholesterol Levels to New Targets on Cardiovascular Complications in Peritoneal Dialysis PatientsWho this might be right forHypercholesterolemia Clinical Research Center for End Stage Renal Disease, Korea 43